MEDOS INTERNATIONAL SARL PULSERIDER Y, 4MM, 10MM ARCH; INTRACRANIAL NEUROVASCULAR STENT
|
Back to Search Results |
|
Model Number 313-D |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problem
Aneurysm (1708)
|
Event Type
Injury
|
Manufacturer Narrative
|
Manufacturer¿s ref.No: (b)(4).Information regarding patient identifier, date of birth, age, gender, weight, race, and ethnicity were not provided.Date of event: the date of the event is not known.The expiration date of the device is not known as the device lot number is not available / not reported.The implantation month, day, and year is not available as the date of the event is not known.The name, phone and email address of the initial reporter are not available / reported.The device manufacture date is not known as the device lot number is not available / not reported.Based on complaint information, the device remains implanted and is thus not available for evaluation.The device lot number was not available.The manufacturing documentation review could not be performed without the lot number.Product analysis cannot be conducted as the product was not returned for analysis.No determination of causes and possible contributing factors could be made.As such, the investigation will be closed.Aneurysm recanalization is a condition requiring additional intervention or retreatment or can be reasonably expected to result in medical or surgical intervention, including hospitalization.Although the device performed as intended and no malfunction has been reported, the relationship of the pulserider anrd to the reported aneurysm recanalization cannot be excluded.Therefore, this event is usfda reportable under title 21 cfr 803 with a classification of ¿serious injury.¿ the file will be re-reviewed if additional information is received at a later date.As part of the post market surveillance program, information from this complaint is trended for statistical signals and corrective / preventive action may be triggered at a later time.Since there was no evidence to suggest the event was related to a manufacturing or design issue, no corrective actions will be taken at this time.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by cerenovus, or its employees that the report constitutes an admission that the product, cerenovus, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Missing information from this report is identified as blank; this information was not provided in the reported event or available at the time of report submission.The manufacturer will submit a supplemental report if new facts arise which materially alter information submitted in a previous mdr report.Additional information will be submitted within 30 days of receipt.
|
|
Event Description
|
During a conference presentation, the physician reported treating a patient with a basilar artery tip aneurysm using a 3.5 to 4.5 mm, 10 mm, y shape pulserider aneurysm neck reconstruction device (anrd) (313d / lot# unknown).The procedure was completed without any problems with continuous flush maintained.It was reported that at the 8-month follow-up, there was confirmation of recanalization within the aneurysm.Therefore, the patient underwent additional embolization via stent-assisted coil embolization using an enterprise stent (catalog / lot# unknown), and coils (device details unknown).
|
|
Manufacturer Narrative
|
Manufacturer¿s ref.No: (b)(4).The purpose of this mdr submission is to include the additional event information received on 11-may-2023 [additional information]: on 11-may-2023, the following additional information was received: the pulserider device size was selected based on the instructions for use (ifu).Section e.1: initial reporter phone: (b)(6).Updated sections: b.4, e.1, e.3, g.3, g.6, h.2, and h.10.The manufacturer will submit a supplemental report if new facts arise which materially alter information submitted in a previous mdr report.Additional information will be submitted within 30 days of receipt.
|
|
Search Alerts/Recalls
|
|
|